Sean Scanlan - Mar 9, 2023 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Innovation Officer
Signature
/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Stock symbol
TMCI
Transactions as of
Mar 9, 2023
Transactions value $
-$12,327
Form type
4
Date filed
3/10/2023, 08:00 PM
Previous filing
Feb 17, 2023
Next filing
May 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Sale -$12.3K -505 -5.06% $24.41 9.47K Mar 9, 2023 Direct F1, F2
transaction TMCI Common Stock Award $0 +22.9K +242.08% $0.00 32.4K Mar 10, 2023 Direct F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 -52K -50% $0.00 52K Mar 10, 2023 Stock Option (Right to Buy) 52K $24.07 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 Includes 8,331 RSUs.
F3 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F4 Includes 31,256 RSUs.
F5 The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date.